Who has invested in Amplyx Pharmaceuticals?

NEA, RiverVest are named among the investors backing Amplyx Pharmaceuticals.

Amplyx Pharmaceuticals Funding: $146M Raised, Series C

Amplyx Pharmaceuticals funding overview

Amplyx Pharmaceuticals is based in San Diego. Amplyx Pharmaceuticals has raised $146M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2017. The round record for Amplyx Pharmaceuticals runs through 2017; nothing later has been disclosed. Investors on record include NEA, RiverVest. 2 distinct backers are named across the disclosed rounds.

Amplyx Pharmaceuticals at a glance

Total raised: $146M
Latest round: Series C
Latest round date: January 2017
Headquarters: San Diego
Notable investors: NEA, RiverVest

Frequently asked about Amplyx Pharmaceuticals funding

How much has Amplyx Pharmaceuticals raised?: Amplyx Pharmaceuticals has raised $146M in total disclosed funding across the rounds on record.
Who has invested in Amplyx Pharmaceuticals?: NEA, RiverVest are named among the investors backing Amplyx Pharmaceuticals.
What was the latest Amplyx Pharmaceuticals funding round?: The most recent disclosed round is a Series C, announced in January 2017.
Where is Amplyx Pharmaceuticals based?: Amplyx Pharmaceuticals is based in San Diego.
When did Amplyx Pharmaceuticals last raise?: The last disclosed Amplyx Pharmaceuticals round closed in January 2017 at Series C.

Totals shown for Amplyx Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.

Amplyx Pharmaceuticals Funding: $146M Raised, Series C

Amplyx Pharmaceuticals funding overview

Amplyx Pharmaceuticals at a glance

Frequently asked about Amplyx Pharmaceuticals funding

Companies related to Amplyx Pharmaceuticals (36)

Browse related funding lists (5)